肿瘤血管生成抑制药的研究进展

下载PDF

导出

摘要肿瘤是一种血管生成依赖性疾病 ,它的生成、转移、复发和预后均与血管生成密切相关。该文综述肿瘤血管生成抑制因子和已进入临床试验的抑制药。

作者王玮琴周慧君

机构地区浙江省中医院药剂科浙江大学药学院

出处《医药导报》 CAS 2004年第4期248-250,共3页 Herald of Medicine

关键词肿瘤血管生成抑制因子生成抑制药肿瘤预防肿瘤治疗

参考文献23

1[1]Detmar M. Tumor angiogenesis[J]. J Investig Dermatol Symp Proc, 2000, 5(1):20-23.
2[2]Compagni A, Christofori G. Recent advances in research on multistage tumorigenesis[J]. Br J Cancer, 2000, 83(1):1-5.
3[3]Carmeliet P, Jain R K. Angiogenesis in cancer and other diseases[J]. Nature, 2000, 407(6801):249-257.
4[4]Meahara Y, Kabasshima A, Koga T, et al. Vascular invasion and poten-tial for tumor angiogenesis and metastases in gastric carcinoma[J]. Surgery, 2000, 128(3):408-416.
5[5]Gervas P, Scholl B, Mainguene C, et al. Angiogenesis of liver metast-ases: role of sinusoidal cndothelial cells [J]. Dis Colon Rectum, 2000,43(7):980-986.
6[6]Moser T L, Stack M S, Aspklin I, et al. Angiostatin binds ATP synthase on the surface of human endothelial cell[J]. Proc Natl Acad Sci USA, 1999, 96(6):2811.
7[7]Lucas R, Holmgren L, Garicia. Mulitiple forms of angiostatin induce apoptosis in endothelial cell[J]. Blood, 1998, 92(12):4730-4741.
8[8]Dxelius J, Larsson H, Sasaki T, et al. Endostain induced tyrosine kinase signaling through the shb adaptor protein regulates endothelial cell apoptosis[J]. Blood, 2000, 95(11):3403-3407.
9[9]O'Reilly M S, Boehm T, Shing Y, et al. Endostain:an endogenous inhibitor of angiogenesis and tomor growth[J]. Cell, 1997, 88(2):277-285.
10[10]Standker L, Schrader M, Kanse S M, et al. Isolation and characteriza-tion of the circulation form of human endostatin[J]. FEBS Lett, 1997, 420(1):129-133.

医药导报

2004年第4期

内容加载中请稍等...